Best Grants for Biotech Startups in 2026

The best biotech grant programs in 2026 center on NIH SBIR/STTR — which is by orders of magnitude the largest single non-dilutive funder for life sciences in the world, with multiple solicitations annually across dozens of institutes. BARDA funds pandemic preparedness and biodefense. CDMRP (DoD medical research) funds specific disease-state research with congressional earmarks. NSF supports biotech with biological foundations. State programs add substantial capital in selected states: Massachusetts Life Sciences Center (with unique small business matching grants that stack on SBIR), Texas CPRIT (cancer-focused), California CIRM (regenerative medicine), and New York Empire State Development life sciences programs. Private programs from disease-specific foundations (ALS Association, Cystic Fibrosis Foundation, American Cancer Society, JDRF, and dozens of others) fund indication-specific research. Y Combinator Bio, IndieBio, and The Engine provide accelerator-grant hybrid pathways. For bootstrapped biotech founders, stacking NIH SBIR Phase I/II with state matching grants (where available) plus disease-specific foundation funding can realistically build $2M-$5M in non-dilutive capital over 24-36 months before any equity raise.

Last updated

This guide and matching listings are refreshed from the Bootstrap Directory database as source data changes.

Data sources

Sources include Grants.gov, SAM.gov, SBIR.gov, CareerOneStop, state agencies, universities, and verified organizations.

Refresh cadence

Listings are checked weekly where source data allows, with stale or closed programs removed from public results.

Verification

Always confirm eligibility, deadlines, and award details on the official source or application page before applying.

Get alerts for this search

Create a free account, run the matching search, and save it to get new funding, grant, or training updates.

Browse the top biotech grant opportunities below, updated weekly from our database of 1,900+ listings. Filter by sub-sector (therapeutics, diagnostics, devices) and stage for best fits.

Featured Opportunities

Job Corps Free Career Training Program

U.S. Department of LaborGRANTEquity-Free
Rolling
Score: 9/10
Verified Jul 10, 2026

VentureWell E-Team Grant Program

VentureWellGRANTEquity-Free
Students only
$20,000
Rolling
Score: 9/10
Verified Jun 16, 2026

NSF CyberCorps Scholarship for Service (SFS)

National Science FoundationGRANTEquity-Free
$25,000 – $34,000
Open
Score: 9/10
Verified Jul 10, 2026

Registered Apprenticeship - Earn While You Learn

U.S. Department of LaborGRANTEquity-Free
Rolling
Score: 9/10
Verified Jul 10, 2026

Federal Pell Grant for Eligible Career Programs

U.S. Department of EducationGRANTEquity-Free
Rolling
Score: 9/10
Verified Jun 5, 2026

MIT Sandbox Innovation Fund Program

Massachusetts Institute of TechnologyGRANTEquity-Free
School-affiliated
$25,000
Rolling
Score: 9/10
Verified Jun 16, 2026

NYS Tuition Assistance Program (TAP) — Non-Degree Programs

NYS Higher Education Services CorporationGRANTEquity-Free
$500 – $5,665
Open
Score: 8/10
Verified Jul 10, 2026

Escape The Hack: Countering Cyber Scams with an Immersive Experience for Everyday Indonesians

DOS-IDNGRANTEquity-Free
Aug 7, 2026
Score: 8/10
Verified Jun 18, 2026

Florida WIOA Training Voucher (CareerSource)

U.S. Department of LaborGRANTEquity-Free
$2,000 – $8,000
Rolling
Score: 8/10
Verified Jun 5, 2026

Ticket to Work Employment and Training Support

Social Security AdministrationGRANTEquity-Free
Rolling
Score: 8/10
Verified Jul 10, 2026

Frequently Asked Questions

Why is NIH SBIR so important for biotech?

NIH operates one of the largest SBIR programs in the federal government with $1+ billion in annual awards. Its structure (Phase I Concept at $150K-$300K, Phase II Prototype at $1M-$2M, Phase IIB and Direct to Phase II at higher levels) is optimally suited to biotech development timelines. Multiple institutes (NCI, NIMH, NHLBI, NIA, NIAID, etc.) have distinct RFAs. Biotech founders routinely build companies on NIH SBIR as the primary capital source for years.

What's the MLSC matching grant?

The Massachusetts Life Sciences Center Small Business Matching Grant provides matching funds to MA-based life sciences companies that win federal SBIR/STTR Phase I or Phase II awards. This effectively doubles non-dilutive funding for qualifying MA companies. It's one of the country's most distinctive state-level biotech advantages and a meaningful factor in biotech location decisions.

How do disease-specific foundations fund biotech?

Disease-focused foundations (ALS Association, JDRF, Cystic Fibrosis Foundation, American Cancer Society, Susan G. Komen, Alzheimer's Association, etc.) run grant and venture philanthropy programs targeting specific indications. Structures range from pure grants to milestone-based funding to non-dilutive preferred-investor arrangements. For founders working in a specific indication, these foundations often provide more targeted capital than generic biotech programs.

Related Pages